GL1X · GenesisL1 explorer

MolNFT v1 · #151563 · protein

Structure of human erythroid-specific 5'-aminolevulinate synthase, ALAS2

6HRH · 5-aminolevulinate synthase, erythroid-specific…: “Structure of human erythroid-specific 5'-aminolevulinate synthase, ALAS2”. X-ray diffraction, 1 ligand (PLP), 11 pockets (best druggability 0.84). MolNFT v1 #151563 on GenesisL1: 3D…

PDB
6HRH
Type
protein
Length
857 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
5-aminolevulinate synthase, erythroid-specific, mitochondrial
EC
2.3.1.37
UniProt
P22557
Ligands
PLP
Pockets
11 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B5-aminolevulinate synthase, erythroid-specific, mitochondrial (EC 2.3.1.37)protein42843% helix, 16% strandP22557
A5-aminolevulinate synthase, erythroid-specific, mitochondrial (EC 2.3.1.37)protein42943% helix, 15% strandP22557

Ligands and binding sites

  • PLP · Pyridoxal-5'-phosphate · ligand · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12250.840.9648PLP
22500.820.9453PLP
31170.470.7919empty
41100.470.7919empty
51650.470.7620empty

Interfaces

1 interface between chains.

  • B–A · 5073 Ų buried · 52 hydrogen bonds · protein-protein

Compared structures

  • 6HRH · Structure of human erythroid-specific 5'-aminolevulinate synthase, ALAS2 · the same entry in another collection · chain B against B, TM-score 1.00
  • P22557 · AlphaFold monomer V2.0 prediction for 5-aminolevulinate synthase, erythroid-specific… · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.